论文信息 - Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study - 字舞流文

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

Maria Knoll | Martin Antonio | Sheikh Jarju | Lamin Ceesay | Uchendu Uchendu | Momodou Jasseh | R. Adegbola | B. Greenwood | K. Mulholland | D. Saha | M. Antonio | D. Jeffries | O. Levine | P. Hill | T. Corrah | S. Howie | Momodou Jasseh | G. Mackenzie | Tumani Corrah | Brian M Greenwood | Richard A Adegbola | U. Ikumapayi | Debasish Saha | H. Badji | A. Fombah | Readon C. Ideh | M. Knoll | Philip C Hill | I. Plumb | Aliu O. Akano | Kim Mulholland | Grant A Mackenzie | David J Jeffries | Ilias Hossain | David Ameh | Malick Ndiaye | Oyedeji Adeyemi | Jayani Pathirana | Yekini Olatunji | Bade Abatan | Bilquees S Muhammad | Augustin E Fombah | Ian Plumb | Aliu Akano | Bernard Ebruke | Readon C Ideh | Bankole Kuti | Peter Githua | Emmanuel Olutunde | Ogochukwu Ofordile | Edward Green | Effua Usuf | Henry Badji | Usman N A Ikumapayi | Ahmad Manjang | Rasheed Salaudeen | E David Nsekpong | Sana Sambou | Yamundow Lowe-Jallow | Orin S Levine | Stephen R Howie | B. Ebruke | S. Jarju | S. Sambou | E. Usuf | I. Hossain | U. Uchendu | D. Ameh | M. Ndiaye | O. Adeyemi | J. Pathirana | Y. Olatunji | B. Abatan | B. Kuti | P. Githua | Emmanuel Olutunde | O. Ofordile | E. Green | A. Manjang | R. Salaudeen | E. D. Nsekpong | L. Ceesay | Y. Lowe-Jallow | Rasheed Salaudeen | Lamin Ceesay | Yekini Olatunji | Yekini A Olatunji | Effua Usuf

[1] B. Greenwood,et al. Pneumococcal disease among children in a rural area of west Africa. , 1996, The Pediatric infectious disease journal.

[2] S. Madhi,et al. Effects of vaccination on invasive pneumococcal disease in South Africa. , 2014, The New England journal of medicine.

[3] R. Adegbola,et al. Monitoring the Introduction of Pneumococcal Conjugate Vaccines into West Africa: Design and Implementation of a Population-Based Surveillance System , 2012, PLoS medicine.

[4] A. von Gottberg,et al. Sequential Triplex Real-Time PCR Assay for Detecting 21 Pneumococcal Capsular Serotypes That Account for a High Global Disease Burden , 2012, Journal of Clinical Microbiology.

[5] D. Goldblatt,et al. Pediatric Invasive Pneumococcal Disease Caused by Vaccine Serotypes following the Introduction of Conjugate Vaccination in Denmark , 2013, PloS one.

[6] M. Virtanen,et al. Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study , 2015, PloS one.

[7] W. Schaffner,et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.

[8] A. Steens,et al. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. , 2013, Vaccine.

[9] R. Cohen,et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10] S. Obaro,et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[11] M. Aidoo,et al. The etiology of pneumonia in malnourished and well-nourished Gambian children. , 1994, The Pediatric infectious disease journal.

[12] N. Andrews,et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. , 2011, The Lancet. Infectious diseases.

[13] K. Mølbak,et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14] A. Walker,et al. Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England. , 2014, The Journal of infectious diseases.

[15] L. Hammitt,et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies , 2014, The Lancet. Global health.

[16] N. Andrews,et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[17] W. Schaffner,et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. , 2015, The Lancet. Infectious diseases.

[18] Steven Black,et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The Journal of pediatrics.

[19] T. Cherian,et al. Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites , 2013, PLoS medicine.

[20] R. D. de Kluyver. Invasive pneumococcal disease surveillance Australia, 1 April to 30 June 2014. , 2014, Communicable diseases intelligence quarterly report.

[21] A. Schuchat,et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.